Search

Search Results

• PO:19:284 | Use of anakinra during pregnancy and breastfeeding in women with recurrent pericarditis: a case series Lucia Trotta¹, Marco Quartarone¹, Francesco Cavaleri¹, Ruggiero Mascolo¹, Massimo Imazio³, Vartan Mardygan², Andreja Cerne Cercek⁴, Anne-Marie Claveau², Ludovico Luca Sicignano⁵, Massimo Pancrazi¹, Alida Caforio⁶, Andrea Silvio Giordani⁶, Serdal Ugurlu⁷, Alessandro Andreis⁸, Valentino Collini³, Enrico Tombetti⁹, Antonio Brucato⁹ | ¹Department of Internal Medicine, ASST Fatebenefratelli-Sacco, Milan, Italy; ²Division of Cardiology, Department of Medicine, Jewish General Hospital, Montréal, Québec, Canada; ³Cardiology, Cardiothoracic Department, University Hospital Santa Maria della Misericordia, Udine, Italy; ⁴Department of Cardiology, University Medical Centre Ljubljana, Ljubljana, Slovenia; ⁵Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy; ⁶Division of Cardiology, Centro Gallucci, University of Padova-Policlinico, Padova, Italy; ⁷Division of Rheumatology, Department of Internal Medicine, Istanbul University-Cerrahpasa, Istanbul, Turkey; ⁸University Cardiology, A.O.U. Città della Salute e della Scienza di Torino, Torino, Italy; ⁹Department of Biomedical and Clinical Sciences, Fatebenefratelli Hospital, University of Milan, Milan, Italy

  Società Italiana di Reumatologia

  18-03-2026

  https://doi.org/10.4081/reumatismo.2025.2340

  73
• 

  Drug survival and reasons for discontinuation of the first course of biological therapy in 301 juvenile idiopathic arthritis patients

  M. Romano, I. Pontikaki, M. Gattinara, I. Ardoino, C. Donati, P. Boracchi, P.L. Meroni, V. Gerloni

  278-285

  17-03-2014

  https://doi.org/10.4081/reumatismo.2013.682

  3025

  PDF: 1468

• Anakinra, a recombinant human IL-1 receptor antagonist, in clinical practice. Outcome in 60 patients with severe rheumatoid arthritis

  C. Botsios, P. Sfriso, A. Furlan, P. Ostuni, M. Biscaro, U. Fiocco, S. Todesco, L. Punzi

  32-37

  https://doi.org/10.4081/reumatismo.2007.32

  1927

  PDF: 864
• 

  Are biological drugs safe in pregnancy?

  A. Calligaro, A. Hoxha, A. Ruffatti, L. Punzi

  304-317

  31-03-2015

  https://doi.org/10.4081/reumatismo.2014.798

  4203

  PDF: 2645

• PO:19:283 | Hospitalization profile and complications in patients with adult-onset Still’s disease: results from a retrospective study of 74 cases Chiara Calabrese¹, Alessandro Tomelleri^1|2, Corrado Campochiaro^1|2, Nicola Farina², Elena Baldissera², Marco Matucci-Cerinic^1|2, Lorenzo Dagna^1|2 | ¹Libera Università Vita-Salute San Raffaele, Milano; ²Unità di Immunologia, Allergologia e malattie rare, IRCCS San Raffaele, Milano, Italy

  Società Italiana di Reumatologia

  25-11-2025

  https://doi.org/10.4081/reumatismo.2025.2172

  166

• The safety of interleukin-1 receptor antagonist (anakinra) in the treatment of rheumatoid arthritis

  L. Riente

  74-79

  https://doi.org/10.4081/reumatismo.2004.1s.74

  929

  PDF: 987

• PO:22:033 | Unraveling VEXAS syndrome: when skin manifestations and monoclonal gammopathy precede hematological myeloid alterations Laura Di Centa¹, Simone Longhino¹, Valeria Manfrè¹, Stefania Sacco¹, Luca Quartuccio¹ | ¹ASST Papa Giovanni XXIII, Bergamo, Italy

  Società Italiana di Reumatologia

  25-11-2025

  https://doi.org/10.4081/reumatismo.2025.2182

  196
• 

  A short history of anti-rheumatic therapy - VII. Biological agents

  G. Pasero, P. Marson, B. Gatto

  185-194

  09-11-2011

  https://doi.org/10.4081/reumatismo.2011.185

  1808

  PDF: 1341
• 

  GISEA: an Italian biological agents registry in rheumatology

  G. Lapadula, G. Ferraccioli, C. Ferri, L. Punzi, F. Trotta

  155-164

  09-11-2011

  https://doi.org/10.4081/reumatismo.2011.155

  2867

  PDF: 1720

• S02:6 | Monocyte-Driven Inflammation and Inflammasome Activation in ANCA-Positive EGPA: Evidence of Persistent Immune Activation During Remission Chiara Baggio¹, Luca Iorio¹, Carlotta Boscaro^2|3, Federica Davanzo¹, Marta Tonello¹, Mattia Albiero⁴, Andrea Doria¹, Paolo Sfriso¹, Roberto Padoan¹, Francesca Oliviero¹ | ¹Rheumatology Unit, Department of Medicine, University of Padova, Italy; ²Department of Medicine, University of Padova, Italy; ³Veneto Institute of Molecular Medicine, Laboratory of Experimental Diabetology, Italy; ⁴Department of Surgery, Oncology, and Gastroenterology, University of Padova, Italy

  Società Italiana di Reumatologia

  18-03-2026

  https://doi.org/10.4081/reumatismo.2025.2392

  33

• PO:10:150 | A case of pulmonary hypertension in Whipple's disease Alba Chiara Pozzi^1|2, Giulia Fontana^1|2, Francesca Crisafulli^1|2, Guarino Daniele³, Monica Salvi³, Massimiliano Palazzini³, Francesco Biagi^4|5, Ilaria Cavazzana^1|2, Franco Franceschini^1|2, Micol Frassi¹. | ¹Rheumatology and Clinical Immunology Unit ERN-ReCONNECT, ASST Spedali Civili, Brescia, Italy; ²Department of Clinical Experimental Sciences, University of Brescia, Brescia; ³IRCCS Azienda Ospedaliero-Universitaria di Bologna, University of Bologna, Cardiology Unit, DIMEC, Bologna; ⁴University of Pavia, Department of Internal Medicine and Therapeutics, Pavia; ⁵Istituti Clinici Scientifici Maugeri IRCCS, Gastroenterology Unit of Pavia Institute, Pavia, Italy.

  Società Italiana di Reumatologia

  25-11-2025

  https://doi.org/10.4081/reumatismo.2025.2026

  167

• PO:19:287 | Cardiac involvement in Still’s disease: a challenge in differential diagnosis Ludovica Manisera¹, Martina Dodaro², Giuseppe Norcia³, Angelica Gattamelata⁴, Nicola Galea⁵, Concetta Torromeo⁶, Gaetano Tanzilli⁷, Fabrizio Conti⁸, Roberta Priori⁹ | ¹Dipartimento di Scienze Cliniche, Internistiche, Anestesiologiche e Cardiovascolari, Università degli Studi di Roma La Sapienza, Roma; ²Dipartimento di Medicina Traslazionale e di Precisione, Università degli Studi di Roma La Sapienza, Roma; ³Dipartimento di Medicina Molecolare, Università degli Studi di Roma La Sapienza, Roma, Italy

  Società Italiana di Reumatologia

  25-11-2025

  https://doi.org/10.4081/reumatismo.2025.2173

  183

• Infections in patients with rheumatoid arthritis receiving anti-cytokine therapy: biological mechanisms and clinical aspects

  C. Botsios, P. Ostuni, P. Sfriso, A. Furlan, U. Fiocco, D. Sgarabotto, S. Todesco

  224-235

  https://doi.org/10.4081/reumatismo.2003.224

  1322

  PDF: 2789

• PO:25:079 | Anifrolumab in refractory dermatomyositis: a case report Chiara Calabrese¹, Corrado Campochiaro^1|2, Giacomo De Luca ^1|2, Veronica Batani¹, Marco Matucci-Cerinic^1|2, Lorenzo Dagna ^1|2 | ¹Dipartimento di Reumatologia e Scienze Mediche, ASST Centro Specialistico Ortopedico Traumatologico Gaetano Pini-CTO Milano; ²Università degli Studi di Milano, Dipartimento di Fisiopatologia Medico-Chirurgica e Trapianti, Milano, Italy

  Società Italiana di Reumatologia

  25-11-2025

  https://doi.org/10.4081/reumatismo.2025.2190

  170
• 

  Long-term treatment with anakinra and canakinumab resolves patellar subchondral erosion in neonatal-onset multisystem inflammatory disease

  A. Leone, R. Manna, E. Verrecchia, M. Cipullo, D. Rigante

  53-55

  01-04-2019

  https://doi.org/10.4081/reumatismo.2019.1142

  1204

  PDF: 1010

• Correlation between radiographic, echographic and MRI changes and rheumatoid arthritis progression

  M.A. Cimmino, M. Parodi, E. Silvestri, G. Garlaschi

  28-40

  https://doi.org/10.4081/reumatismo.2004.1s.28

  1187

  PDF: 3025